| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(L) | 372 | 58.5% | -1.01 | 185 | 59.1% |
| CentralBrain-unspecified | 84 | 13.2% | -1.81 | 24 | 7.7% |
| CA(L) | 73 | 11.5% | -3.87 | 5 | 1.6% |
| CRE(L) | 28 | 4.4% | 0.36 | 36 | 11.5% |
| b'L(L) | 26 | 4.1% | -1.00 | 13 | 4.2% |
| SLP(L) | 29 | 4.6% | -2.86 | 4 | 1.3% |
| PED(L) | 13 | 2.0% | -0.24 | 11 | 3.5% |
| PLP(L) | 3 | 0.5% | 2.74 | 20 | 6.4% |
| SCL(L) | 7 | 1.1% | 1.10 | 15 | 4.8% |
| bL(L) | 1 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg-s4 | % In | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 58 | DA | 122 | 20.5% | 0.8 |
| KCg-m (L) | 93 | DA | 118 | 19.9% | 0.7 |
| APL (L) | 1 | GABA | 30 | 5.1% | 0.0 |
| KCg-s2 (L) | 1 | DA | 29 | 4.9% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 29 | 4.9% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 27 | 4.5% | 0.0 |
| PAM08 (L) | 8 | DA | 24 | 4.0% | 1.0 |
| KCg-s3 (L) | 1 | DA | 23 | 3.9% | 0.0 |
| PPL103 (R) | 1 | DA | 21 | 3.5% | 0.0 |
| PPL103 (L) | 1 | DA | 20 | 3.4% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 19 | 3.2% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 16 | 2.7% | 0.0 |
| PAM07 (L) | 4 | DA | 15 | 2.5% | 0.5 |
| VP1d_il2PN (L) | 1 | ACh | 10 | 1.7% | 0.0 |
| KCg-s1 (L) | 1 | DA | 7 | 1.2% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 7 | 1.2% | 0.0 |
| DPM (L) | 1 | DA | 6 | 1.0% | 0.0 |
| SLP360_b (L) | 1 | ACh | 5 | 0.8% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 5 | 0.8% | 0.0 |
| KCab-p (L) | 4 | DA | 5 | 0.8% | 0.3 |
| KCg (L) | 1 | DA | 4 | 0.7% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 4 | 0.7% | 0.0 |
| PAM08 (R) | 3 | DA | 4 | 0.7% | 0.4 |
| PAM12 (R) | 4 | DA | 4 | 0.7% | 0.0 |
| PAM12 (L) | 4 | DA | 4 | 0.7% | 0.0 |
| CB0951 (R) | 1 | Glu | 3 | 0.5% | 0.0 |
| MBON12 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| KCa'b'-ap1 (L) | 3 | DA | 3 | 0.5% | 0.0 |
| PPL202 (L) | 1 | DA | 2 | 0.3% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| MeVP49 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PAM05 (L) | 2 | DA | 2 | 0.3% | 0.0 |
| SLP461 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV4c1_c (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP007 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 1 | 0.2% | 0.0 |
| PAM05 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| PAM02 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| SLP361 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| KCab-m (L) | 1 | DA | 1 | 0.2% | 0.0 |
| AOTU056 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| PLP095 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PPM1201 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.2% | 0.0 |
| PPL101 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| MBON33 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP550 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| V_ilPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MBON05 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns KCg-s4 | % Out | CV |
|---|---|---|---|---|---|
| KCg-m (L) | 111 | DA | 154 | 17.9% | 0.5 |
| KCg-d (L) | 59 | DA | 118 | 13.8% | 0.8 |
| PAM08 (L) | 11 | DA | 44 | 5.1% | 1.0 |
| KCg-s2 (L) | 1 | DA | 37 | 4.3% | 0.0 |
| MBON09 (L) | 2 | GABA | 35 | 4.1% | 0.0 |
| MBON05 (R) | 1 | Glu | 31 | 3.6% | 0.0 |
| KCg-s3 (L) | 1 | DA | 27 | 3.1% | 0.0 |
| APL (L) | 1 | GABA | 22 | 2.6% | 0.0 |
| PPL103 (R) | 1 | DA | 19 | 2.2% | 0.0 |
| DPM (L) | 1 | DA | 19 | 2.2% | 0.0 |
| MBON26 (L) | 1 | ACh | 18 | 2.1% | 0.0 |
| MBON32 (L) | 1 | GABA | 16 | 1.9% | 0.0 |
| MBON35 (L) | 1 | ACh | 16 | 1.9% | 0.0 |
| MBON33 (L) | 1 | ACh | 15 | 1.7% | 0.0 |
| PAM07 (L) | 5 | DA | 15 | 1.7% | 0.5 |
| PAM08 (R) | 8 | DA | 15 | 1.7% | 0.6 |
| MBON04 (R) | 1 | Glu | 11 | 1.3% | 0.0 |
| PPL103 (L) | 1 | DA | 11 | 1.3% | 0.0 |
| KCg-s1 (L) | 1 | DA | 10 | 1.2% | 0.0 |
| MBON01 (L) | 1 | Glu | 9 | 1.0% | 0.0 |
| PLP007 (L) | 1 | Glu | 9 | 1.0% | 0.0 |
| MBON11 (L) | 1 | GABA | 9 | 1.0% | 0.0 |
| CRE080_d (L) | 1 | ACh | 7 | 0.8% | 0.0 |
| CL359 (L) | 2 | ACh | 7 | 0.8% | 0.4 |
| MBON12 (L) | 2 | ACh | 7 | 0.8% | 0.4 |
| PAM12 (L) | 4 | DA | 7 | 0.8% | 0.5 |
| KCa'b'-ap1 (L) | 5 | DA | 7 | 0.8% | 0.6 |
| KCg (L) | 1 | DA | 5 | 0.6% | 0.0 |
| CB0670 (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| CL109 (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| PAM12 (R) | 4 | DA | 5 | 0.6% | 0.3 |
| KCab-p (L) | 5 | DA | 5 | 0.6% | 0.0 |
| LHPD5d1 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| LoVP97 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| CB0951 (R) | 1 | Glu | 3 | 0.3% | 0.0 |
| FB4K (R) | 1 | Glu | 3 | 0.3% | 0.0 |
| CB3874 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV8a1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LoVP100 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| MBON21 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| CL063 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| CRE200m (R) | 2 | Glu | 3 | 0.3% | 0.3 |
| PLP003 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| CB3676 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MBON27 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| MBON30 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| PAM02 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| SMP174 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| CRE108 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CL356 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PPL202 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| VES025 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MBON22 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PPL101 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| MBON11 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| MBON20 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| LAL198 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| GNG661 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MBON06 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| PAM05 (L) | 2 | DA | 2 | 0.2% | 0.0 |
| PAM01 (R) | 2 | DA | 2 | 0.2% | 0.0 |
| SLP461 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP376 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1326 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP049 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON29 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE080_c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON09 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL032 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE012 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| mALD3 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON29 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VL1_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP003 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON30 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE049 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2059 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP255 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LAL043_d (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE049 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL070_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL263 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP359 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP285 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV5m1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM05 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| LHPV6f1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3093 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2113 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP362 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM01 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| FB4D_a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE024 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE027 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL127 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP473 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP095 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP248 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP184 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ATL026 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| AVLP038 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP311 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe26 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV8a1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP45 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE048 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| AVLP475_a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPM1201 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| CRE050 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| MeVP49 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP131 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LAL159 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| FLA016 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
